Robert Crotty, General Counsel & Secretary at Nabriva Therapeutics plc (NBRV), bought 10,000 shares at $4.48 ($45K) on 2018-05-23, disclosed to the SEC on 2018-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.